Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 5 Oct 22 S-8 POS Registration of securities for employees (post-effective amendment)
-
31 Jan 22 S-8 Registration of securities for employees
GBT similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Global Blood Therapeutics, Inc.:
We consent to the use of our report dated February 24, 2021, with respect to the consolidated financial statements of Global Blood Therapeutics, Inc., and the effectiveness of internal control over financial reporting, incorporated herein by reference.
/s/ KPMG LLP
San Francisco, California
January 31, 2022